RTRX Research and Charts

RTRX - Retrophin Inc (Healthcare: Drug Manufacturers - Major)

Projected Earnings Date: 2019-11-04 (Delayed quote data 2025-01-03)

Last 18.86	Change ⇓ -0.11 (-0.58%)	Volume 999,626
	Open 19.10	High 19.23	Low 18.72

8EMA (Daily) 18.00	40EMA (Daily) 17.74	50EMA (Daily) 17.49	STO (Daily) 54.335	MACD Hist (Daily) 0.246
8EMA (Weekly) 17.847	40EMA (Weekly) 13.79	50EMA (Weekly) 13.36	STO (Weekly) 69.257	MACD Hist (Weekly) -0.147


Company Profile
Retrophin Inc is a fully integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.